BARBAGLIA, Matteo Nazzareno

BARBAGLIA, Matteo Nazzareno  

Dipartimento di Medicina Traslazionale  

Mostra records
Risultati 1 - 11 di 11 (tempo di esecuzione: 0.028 secondi).
Titolo Data di pubblicazione Autore(i) File
17,β-estradiol inhibits hepatitis C virus mainly by interference with the release phase of its life cycle 1-gen-2017 Magri, Andrea; Barbaglia, Matteo Nazzareno; Foglia, Chiara Z.; Boccato, Elisa; Burlone, MICHELA Emma; Cole, Sarah; Giarda, Paola; Grossini, Elena; Patel, Arvind H.; Minisini, Rosalba; Pirisi, Mario
17β-Oestradiol Protects from Hepatitis C Virus Infection through Induction of Type I Interferon 1-gen-2022 Barbaglia, Matteo Nazzareno; Harris, James Michael; Smirnov, Artem; Burlone, Michela Emma; Rigamonti, Cristina; Pirisi, Mario; Minisini, Rosalba; Magri, Andrea
Detrimental Impact of Interferon-Based Regimens for Chronic Hepatitis C on Vitamin D/Parathyroid Hormone Homeostasis 1-gen-2018 Salmi, L; Barbaglia, Mn; Smirne, C; Bianco, S; Guaschino, G; Crobu, Mgs; Minisini, R; Pirisi, M
Direct antivirals and cognitive impairment in hepatitis C: a clinical-neurophysiologic study 1-gen-2020 Vaghi, G.; Gori, B.; Strigaro, G.; Burlone, M.; Minisini, R.; Barbaglia, M. N.; Brigatti, E.; Varrasi, C.; Pirisi, M.; Cantello, R.
Finding the seed of recurrence: Hepatocellular carcinoma circulating tumor cells and their potential to drive the surgical treatment 1-gen-2021 Carissimi, Francesca; Barbaglia, Matteo Nazzareno; Salmi, Livia; Ciulli, Cristina; Roccamatisi, Linda; Cordaro, Giuseppe; Mallela, Venkata Ramana; Minisini, Rosalba; Leone, Biagio Eugenio; Donadon, Matteo; Torzilli, Guido; Pirisi, Mario; Romano, Fabrizio; Famularo, Simone
Gas6 as a predictor of esophageal varices in patients affected by hepatitis C virus related-chronic liver disease 1-gen-2018 Bellan, Mattia; Sainaghi, Pier Paolo; Minh, Margherita Tran; Minisini, Rosalba; Molinari, Luca; Baldrighi, Marco; Salmi, Livia; Barbaglia, Matteo Nazzareno; Castello, Luigi Mario; Ravanini, Paolo; Avanzi, Gian Carlo; Pirisi, Mario
HSD17B13 and other liver fat-modulating genes predict development of hepatocellular carcinoma among HCV-positive cirrhotics with and without viral clearance after DAA treatment 1-gen-2022 Burlone, M. E.; Bellan, M.; Barbaglia, M. N.; Mocchetti, G.; Mallela, V. R.; Minisini, R.; Rigamonti, C.; Pirisi, M.
Interplay of PNPLA3 and HSD17B13 Variants in Modulating the Risk of Hepatocellular Carcinoma among Hepatitis C Patients 1-gen-2020 De Benedittis, C.; Bellan, M.; Crevola, M.; Boin, E.; Barbaglia, M. N.; Mallela, V. R.; Ravanini, P.; Ceriani, E.; Fangazio, S.; Sainaghi, P. P.; Burlone, M. E.; Minisini, R.; Pirisi, M.
Periostin Circulating Levels and Genetic Variants in Patients with Non-Alcoholic Fatty Liver Disease 1-gen-2020 Smirne, Carlo; Mulas, Violante; Barbaglia, Matteo Nazzareno; Ramana Mallela, Venkata; Minisini, Rosalba; Barizzone, Nadia; Burlone, MICHELA Emma; Pirisi, Mario; Grossini, Elena
Severity of nonalcoholic fatty liver disease in type 2 diabetes mellitus: Relationship between nongenetic factors and PNPLA3/HSD17B13 polymorphisms 1-gen-2019 Bellan, M.; Colletta, C.; Barbaglia, M. N.; Salmi, L.; Clerici, R.; Mallela, V. R.; Castello, L. M.; Saglietti, G.; Carnevale Schianca, G. P.; Minisini, R.; Pirisi, M.
Sex differences in hepatitis C virus infection: characterisation of 17,β-estradiol-modulated antiviral defences in an HCV cell culture system 1-gen-2021 Barbaglia, Matteo